Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma
Sign Up to like & getrecommendations! Published in 2019 at "Laboratory Investigation"
DOI: 10.1038/s41374-019-0318-6
Abstract: Cancer cells, including malignant lymphoma cells, alter their metabolism, termed “metabolic reprograming,” on initiation of malignant transformation as well as upon accumulation of genetic abnormalities. Here, to identify a novel therapeutic target involved in the… read more here.
Keywords: fatty acid; hadha; therapeutic target; malignant lymphoma ... See more keywords